Key result
Viscoelastic point-of-care testing cuts transfusions in cardiac surgery but fails to reduce mortality.
Meta-Analysis (n=8,737)
Answers are grounded in this paper and cite their sources.
Viscoelastic point-of-care tests are commonly used to provide prompt diagnosis of coagulopathy and allow targeted treatments in bleeding patients. We updated existing meta-analyses that have evaluated the clinical effectiveness of viscoelastic point-of-care tests vs the current standard of care for the management of cardiac surgery patients at risk of coagulopathic bleeding. Randomized controlled trials comparing viscoelastic point-of-care diagnostic testing with standard care in cardiac surgery patients were sought. All-cause mortality, blood loss, reoperation, blood transfusion, major morbidity, and intensive care unit and hospital length of stay were analysed using random-effects modelling. Fifteen trials that randomized a total of 8737 participants were included for the analysis. None of the trials was classified as low risk of bias. The use of thromboelastography- (TEG®) or thromboelastometry (ROTEM®)-guided algorithms did not reduce mortality [risk ratio (RR) 0.55, 95% confidence interval (CI) 0.28-1.10] without heterogeneity (I2=1%), reoperation for bleeding, stroke, ventilation time, or hospital length of stay compared with standard care. Use of TEG® or ROTEM® resulted in reductions in the frequency of red blood cell (Risk Ratio 0.88, 95% Confidence Interval 0.79-0.97; I2=43%) and platelet transfusion (Risk Ratio 0.78, 95% Confidence Interval 0.66-0.93; I2=0%). Group Reading Assessment and Diagnostic Evaluation (GRADE) assessment demonstrated that the quality of the evidence was low or very low for all estimated outcomes. Routine use of viscoelastic point-of-care tests did not improve important clinical outcomes beyond transfusion in adults undergoing cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Serraino et al. (2017) conducted a meta-analysis in Coagulopathic bleeding in cardiac surgery (n=8,737). Viscoelastic point-of-care testing (TEG or ROTEM) vs. Standard of care was evaluated on All-cause mortality (RR 0.55, 95% CI 0.28-1.10). Viscoelastic point-of-care tests reduced RBC and platelet transfusions in cardiac surgery, without reducing mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: